StonvexLoading…
StonvexStonvexStonvexCore line items from DNUT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-29 | Annual 2025 2025-12-28 | Q3 2025 2025-09-28 | Q2 2025 2025-06-29 |
|---|---|---|---|---|
Revenue | $367.03M | $1.52B | $1.13B | $754.95M |
Operating Income | $-3.63M | $-469.27M | $-462.00M | $-454.82M |
Net Income | $-22.78M | $-515.77M | $-487.99M | $-468.54M |
EPS (Diluted) | $-0.16 | $-3.04 | $-2.86 | $-2.75 |
Total Assets | $2.39B | $2.59B | $2.60B | $2.63B |
Total Liabilities | $1.75B | $1.92B | $1.91B | $1.91B |
Cash & Equivalents | $74.22M | $42.39M | $30.71M | $21.26M |
Free Cash Flow OCF − CapEx | $11.38M | $-64.00M | $-91.94M | $-107.48M |
Shares Outstanding | 172.28M | 171.56M | 171.24M | 170.96M |